Abstract
The CAPP2 investigators report on the long-term effects of resistant starch (RS) on the incidence of colorectal cancer and other Lynch syndrome-related tumors in the trial population of the CAPP-2 study. RS has no effect on colorectal cancer incidence, but it reduced the numbers of other Lynch syndrome-related tumors, mainly driven by upper gastrointestinal cancers. Although the study has limitations related to secondary analysis, it fills an important void in the field of cancer interception of non-colorectal Lynch syndrome-related tumors and should form the basis for future trials of RS in Lynch syndrome.
Original language | English (US) |
---|---|
Pages (from-to) | 557-559 |
Number of pages | 3 |
Journal | Cancer Prevention Research |
Volume | 15 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2022 |
ASJC Scopus subject areas
- Oncology
- Cancer Research